Literature DB >> 27231284

Foreign Medical Teams in support of the Ebola outbreak: a UK military model of pre-deployment training and assurance.

Christopher Gibson1, T Fletcher2, K Clay1, A Griffiths3.   

Abstract

We discuss the training methodology developed and utilised to prepare UK military medical teams to establish an Ebola Treatment Centre in Sierra Leone. We highlight the process of identifying and mitigating nosocomial risk in the Pre-Deployment Training process, encompassing the challenges of developing, training and assuring a capability at pace, which deployed to deliver high quality clinical care to patients with Ebola Virus Disease. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Ebola Virus Disease; INFECTIOUS DISEASES; MEDICAL EDUCATION & TRAINING

Mesh：

Year:  2016        PMID： 27231284     DOI： 10.1136/jramc-2016-000620

Source DB:  PubMed          Journal:  J R Army Med Corps        ISSN： 0035-8665            Impact factor:   1.285


  3 in total

1.  Lessons from the organisation of the UK medical services deployed in support of Operation TELIC (Iraq) and Operation HERRICK (Afghanistan).

Authors:  Martin C M Bricknell; M Nadin
Journal:  J R Army Med Corps       Date:  2017-01-06       Impact factor: 1.285

2.  Personal protective equipment solution for UK military medical personnel working in an Ebola virus disease treatment unit in Sierra Leone.

Authors:  P Reidy; T Fletcher; C Shieber; J Shallcross; H Towler; M Ping; L Kenworthy; N Silman; E Aarons
Journal:  J Hosp Infect       Date:  2017-03-18       Impact factor: 3.926

3.  Enhanced case management can be delivered for patients with EVD in Africa: Experience from a UK military Ebola treatment centre in Sierra Leone.

Authors:  S J Dickson; K A Clay; M Adam; C Ardley; M S Bailey; D S Burns; A T Cox; D G Craig; M Espina; I Ewington; G Fitchett; J Grindrod; D E Hinsley; S Horne; E Hutley; A M Johnston; R L C Kao; L E Lamb; S Lewis; D Marion; A J Moore; T C Nicholson-Roberts; A Phillips; J Praught; P S Rees; I Schoonbaert; T Trinick; D R Wilson; A J Simpson; D Wang; M K O'Shea; T E Fletcher
Journal:  J Infect       Date:  2017-12-14       Impact factor: 6.072
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.